Cathie Wood's ARK Invest Buys Nearly 1.5 Million Shares of Ginkgo Bioworks

Investing

Published: December 2, 2021 8:05 am

A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these funds bought roughly $17 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these funds were down sharply on Wednesday.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 485,075 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 995,250 shares. At Wednesday’s closing price, this would have valued the sales at roughly $16.9 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 26% and the other is down 11% in the past year.

Check out all the ARK Invest purchases for Wednesday as well:

Fund	Ticker	Name	Shares
ARKF	SE	SEA	25,964
ARKF	TWLO	TWILIO	25,714
ARKF	TOST	TOAST	151,274
ARKF	DSYSJ	DISCOVERY	26,840
ARKG	ONEM	1LIFE HEALTHCARE	450,594
ARKG	DNA	GINKGO BIOWORKS	485,075
ARKG	VCYT	VERACYTE	70,279
ARKG	SDGR	SCHRODINGER	78,197
ARKG	SURF	SURFACE ONCOLOGY	250,000
ARKG	MASS	908 DEVICES	52,228
ARKG	SLGC	SOMALOGIC	39,998
ARKK	ZM	ZOOM VIDEO COMMUNICATIONS	132,250
ARKK	TRMB	TRIMBLE	251,411
ARKK	TWLO	TWILIO	66,987
ARKK	DNA	GINKGO BIOWORKS	995,250
ARKK	MTLS	MATERIALISE	45,325
ARKK	SGFY	SIGNIFY HEALTH	64,300
ARKK	NTLA	INTELLIA THERAPEUTICS	100
ARKQ	BLDE	BLADE AIR MOBILITY	315,689
ARKQ	ACHR	ARCHER AVIATION	150,906
ARKQ	MKFG	MARKFORGED	123,400
ARKW	ZM	ZOOM VIDEO COMMUNICATIONS	33,372
ARKX	VLD	VELO3D	35,426

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.